DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

98 hedge funds and large institutions have $901M invested in Dicerna Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
Holders Change %
0%
% of All Funds
2.13%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
18
Increased
33
Reduced
27
Closed
16
Calls
$189K
Puts
Net Calls
+$189K
Net Calls Change
+$189K
Name Holding Trade Value Shares
Change
Shares
Change %
Assenagon Asset Management
101
Assenagon Asset Management
Luxembourg
-$4.5M -307,262 Closed
Federated Hermes
102
Federated Hermes
Pennsylvania
-$4.22M -287,961 Closed
Marshall Wace
103
Marshall Wace
United Kingdom
-$2.96M -202,213 Closed
OFM
104
Omega Fund Management
Massachusetts
-$2.45M -167,157 Closed
MWNA
105
Marshall Wace North America
New York
-$261K -17,886 Closed
HF
106
HRT Financial
New York
-$198K -13,549 Closed
B
107
Bailard
California
-$192K -13,100 Closed
ECM
108
Element Capital Management
New York
-$192K -13,080 Closed
AIMCA
109
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$188K -12,800 Closed
EMG
110
Ellington Management Group
Connecticut
-$160K -10,900 Closed
Jane Street
111
Jane Street
New York
-$153K -10,412 Closed
TRCT
112
Tower Research Capital (TRC)
New York
-$37K -2,569 Closed
KPW
113
Kore Private Wealth
New York
-$7K -500 Closed